Skip to main content

Table 2 Comparison of hepatic steatosis indices between statin users and non-users

From: Screening for the presence of scleroedema adultorum of Buschke in patients with diabetes mellitus: newly diagnosed patients had a high prevalence of dyslipidaemia

 

Statin users

Non-users

S1

S2

DM-without-S

S1

S2

DM-without-S

n = 9

n = 9

n = 44

n = 2

n = 6

n = 56

Hepatic steatosis index (IQR)

50.4 (6.5)*

46.8 (5.5)

42.4 (10.1)

51.6 (N.A)

44.6 (9.4)

42.9 (10.6)

Framingham

steatosis index (IQR)

1.12 (0.9)*

0.72 (1.7)

0.024 (1.9)

1.5 (N.A.)

0.15 (2.1)

−0.23 (1.9)

  1. S1: newly diagnosed patients with scleroedema out of 113 consecutive patients with diabetes mellitus (DM); S2: 15 patients with diabetes and scleroedema adultorum of Buschke treated in a tertiary care centre; DM-without-S: consecutive diabetes patients without scleroedema. *P < 0.05 values are for the comparisons of lipid parameters between patients with scleroedema and those with diabetes without scleroedema. Data are expressed as median (interquartile range, IQR). Mann Whitney U test was applied to calculate P-values
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X